Cancer Research Teams Working to Identify Early Biomarkers of Ovarian Cancer

Cancer Research Teams Working to Identify Early Biomarkers of Ovarian Cancer
With a $544,360 developmental grant from the U.S. Department of Defense (DoD), four research teams are joining efforts to identify biomarkers of ovarian cancer with a goal of detecting the disease earlier or before it even develops. The collaboration, named DoD and SPORE Ovarian Cancer Omics Consortium, will include researchers at Inova, specifically the healthcare provider's Women's Health Integrated Research Center, and teams at Roswell Park Comprehensive Cancer Center (in collaboration with the University of Pittsburgh Cancer Institute), the Mayo Clinic, and MD Anderson Cancer Center. "I don't believe there has ever been such a united effort in medical science among researchers from both government and academic research organizations," Larry Maxwell, MD, chair of obstetrics and gynecology at Inova Fairfax Women's Hospital and co-principal investigator of the effort, said in a press release. Women with ov
Subscribe or to access all post and page content.